Vaccine Adjuvants Global Market Report 2024

Global Vaccine Adjuvants Market Report 2024

Vaccine Adjuvants Global Market Report 2024 – By Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types), By Route of Application (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), By Route of Administration (Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal), By Disease (Cancer, Infectious Diseases, Other Diseases) – Market Size, Trends, And Global Forecast 2024-2033

Name: Vaccine Adjuvants Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Vaccine Adjuvants Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Vaccine Adjuvants Global Market Report 2024

Proud Members Of

Vaccine Adjuvants Market Definition

Vaccine adjuvants are compounds or ingredients used in vaccines that enhance the body's immunogenic response to antigens that lack immunostimulatory capabilities and help to create a stronger immune response.

The main types of products of vaccine adjuvants are adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and others such as saponin-based adjuvants. An adjuvant emulsion is a mixture of two or more ordinarily immiscible liquids. The route of application includes human vaccine adjuvants and veterinary vaccine adjuvants administered through oral, intramuscular, intranasal, subcutaneous, and intradermal routes to treat cancer, infectious diseases, and other diseases including zoonotic diseases.

Vaccine Adjuvants Market Segmentation

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Global Vaccine Adjuvants Market Size 2023 to 2028: Graph

Vaccine Adjuvants Market Size 2024 And Growth Rate

The vaccine adjuvants market size has grown strongly in recent years. It will grow from $1.77 billion in 2023 to $1.91 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing vaccine development, prevalence of infectious diseases, government initiatives and immunization programs, research and development investments, globalization of vaccine distribution.

Vaccine Adjuvants Market Growth Forecast

The vaccine adjuvants market size is expected to see strong growth in the next few years. It will grow to $2.62 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine portfolio, global immunization goals, collaborations and partnerships, focus on therapeutic vaccines. Major trends in the forecast period include advancements in adjuvant technologies, focus on immunogenicity enhancement, combination adjuvants for enhanced effectiveness, demand for safer and well-tolerated adjuvants, personalized vaccines and adjuvants.

Book your 30 minutes free consultation with our research experts

Vaccine Adjuvants Market Driver: Rising Infectious Disease Prevalence Fuels Growth In The Vaccine Adjuvants Market

The rising prevalence of infectious diseases is expected to propel the growth of the vaccine adjuvants market going forward. Infectious diseases refer to infections caused by viruses, bacteria, fungi, or parasites. Vaccines are used to treat these infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For instance, according to the 2022 World Health Organization (WHO) report, an estimated 10.6 million people are infected with tuberculosis globally in 2021, 1.6 million died, and 1.5 million people acquired HIV in 2021 while 650,000 people lost their lives due to it. Therefore, the rising prevalence of infectious diseases will drive the vaccine adjuvants market.

Vaccine Adjuvants Market Driver: Elevated Funding For Vaccine Research Initiatives Catalyst For Growth In The Vaccine Adjuvants Market

The growing funding for vaccine research activities is expected to propel the growth of the vaccine adjuvants market going forward. Vaccine research activities can be defined as comprehensive scientific endeavors aimed at developing, testing, and improving vaccines to prevent infectious diseases. Research activities play a vital role in developing, testing, and optimizing potential adjuvant candidates from various sources, including natural products, synthetic compounds, and even bacteria or viruses. For instance, in October 2023, the United States Department of Health and Human Services, a US-based provider of essential human services, announced Project NextGen with a $500 Million investment to begin developing Phase 2b clinical trial plans and technologies that develop cutting-edge next-generation vaccination and treatment platforms. Therefore, the growing funding for vaccine research activities is driving the growth of the vaccine adjuvants market.

Global Vaccine Adjuvants Market Major Players

Major companies operating in the vaccine adjuvants market report are GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Global Vaccine Adjuvants Market Trend: Surge In Strategic Partnerships Shapes The Landscape Of The Vaccine Adjuvants Market

Strategic partnership is a key trend gaining popularity in the vaccine adjuvants market. Many companies operating in the vaccine adjuvants market are looking for partnerships to strengthen their position in the market. For instance, in October 2021, Dynavax Technologies, a US-based biotech company partnered with the U.S. Department of Defense to develop an adjuvanted plague vaccine using Dynavax's CpG 1018 adjuvant. Furthermore, in September 2020, Valneva SE, a France-based biotech company, partnered with Dynavax, a US-based biotech company to produce an adjuvant for the COVID-19 vaccine.

Global Vaccine Adjuvants Market Trend: Innovation In The Vaccine Adjuvants Market With A Plant-Based Squalene For Enhanced Vaccine Efficacy

Major companies operating in the vaccine adjuvants market are focused on developing innovative products, such as plant-based squalene, to gain a competitive edge in the market. Plant-based squalene is a sustainable and cruelty-free alternative to the traditional squalene derived from shark liver oil. For instance, in December 2022, Evonik Industries AG, a Germany-based specialty chemicals company, launched PhytoSquene, a plant-based squalene for use in adjuvants to boost vaccine efficacy. It is used in adjuvants for parenteral vaccines, with potential for expansion into other pharmaceutical and cosmetic applications. The oil used to make PhytoSquene comes from the herbaceous plant known as amaranth (Amaranthus caudatus), which is grown all over the world. Its botanical origin guarantees purity, quality, and consistency from batch to batch. For patients who are unable to utilize products derived from animals due to cultural or religious beliefs, PhytoSquene offers an additional solution.

Vaccine Adjuvants Market Merger And Acquisition: Gsk Enhances Portfolio With Acquisition Of Affinivax Inc. In Vaccine Adjuvants Market

In August 2022, GSK plc, a UK-based pharmaceutical and biotechnology company, acquired Affinivax Inc. for a deal amount of $3.3 billion. The acquisition of Affinivax strengthens GSK's strategy to build a substantial portfolio of specialized novel drugs and vaccines. It comprises a next-generation 24-valent pneumococcal vaccine adjuvant (AFX3772), which is based on the incredibly ground-breaking Multiple Antigen Presenting System (MAPSTM) platform technology and is currently in phase II development. Affinivax Inc. is a UK-based clinical-stage biopharmaceutical company operating in the vaccine adjuvant market.

Regional Analysis For The Global Vaccine Adjuvants Market

North America was the largest region in the vaccine adjuvants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vaccine adjuvants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The vaccine adjuvants market consists of sales of adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and saponin-based adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The vaccine adjuvants market research report is one of a series of new reports from The Business Research Company that provides vaccine adjuvants market statistics, including the vaccine adjuvants industry's global market size, regional shares, competitors with a vaccine adjuvants market share, detailed vaccine adjuvants market segments, market trends, and opportunities, and any further data you may need to thrive in the vaccine adjuvants industry. This vaccine adjuvants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vaccine Adjuvants Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$1.91 billion
Revenue Forecast In 2033	$2.62 billion
Growth Rate	CAGR of 8.2% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types 2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants 3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal 4) By Disease: Cancer, Infectious Diseases, Other Diseases
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	GlaxoSmithKline Plc.; Novavax Inc.; SPI Pharma Inc.; Agenus Inc.; CSL Limited; InvivoGen Limited.; Brenntag Biosector A/S; Adjuvatis; Merck KGaA; Croda International Plc; Seppic Inc; OZ Biosciences; Avanti Polar Lipids Inc; Astellas Pharma Inc; Virometix AG; MPV Technologies Limited; Adjuvance Technologies Inc.; Novartis AG; Vaxine Pty Ltd; SBI Biotech Co. Ltd.; Statens Serum Institute; GSK Vaccines; VaxLiant LLC; VaxForm LLC; Serum Institute of India; Dynavax Technologies Corporation; Vaxcyte Inc.; VBI Vaccines Inc.; Medicago Inc.; Aphios Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Vaccine Adjuvants Market Characteristics

3. Vaccine Adjuvants Market Trends And Strategies

4. Vaccine Adjuvants Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market

4.2. Ukraine-Russia War Impact On the Market

4.3. COVID-19 Impact On the Market

5. Global Vaccine Adjuvants Market Size and Growth

5.1. Global Vaccine Adjuvants Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Vaccine Adjuvants Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Vaccine Adjuvants Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Vaccine Adjuvants Market Segmentation

6.1. Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Adjuvant Emulsions

Pathogen Components

Particulate Adjuvants

Combination Adjuvants

Other Product Types

6.2. Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Human Vaccine Adjuvants

Veterinary Vaccine Adjuvants

6.3. Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Oral

Intramuscular

Intranasal

Subcutaneous

Intradermal

6.4. Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Cancer

Infectious Diseases

Other Diseases

7. Vaccine Adjuvants Market Regional And Country Analysis

7.1. Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Vaccine Adjuvants Market

8.1. Asia-Pacific Vaccine Adjuvants Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Vaccine Adjuvants Market

9.1. China Vaccine Adjuvants Market Overview

9.2. China Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Vaccine Adjuvants Market

10.1. India Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Vaccine Adjuvants Market

11.1. Japan Vaccine Adjuvants Market Overview

11.2. Japan Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Vaccine Adjuvants Market

12.1. Australia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Vaccine Adjuvants Market

13.1. Indonesia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Vaccine Adjuvants Market

14.1. South Korea Vaccine Adjuvants Market Overview

14.2. South Korea Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Vaccine Adjuvants Market

15.1. Western Europe Vaccine Adjuvants Market Overview

15.2. Western Europe Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Vaccine Adjuvants Market

16.1. UK Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Vaccine Adjuvants Market

17.1. Germany Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Vaccine Adjuvants Market

18.5. France Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Vaccine Adjuvants Market

19.9. Italy Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Vaccine Adjuvants Market

20.13. Spain Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Vaccine Adjuvants Market

21.1. Eastern Europe Vaccine Adjuvants Market Overview

21.2. Eastern Europe Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Vaccine Adjuvants Market

22.1. Russia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Vaccine Adjuvants Market

23.1. North America Vaccine Adjuvants Market Overview

23.2. North America Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Vaccine Adjuvants Market

24.1. USA Vaccine Adjuvants Market Overview

24.2. USA Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Vaccine Adjuvants Market

25.1. Canada Vaccine Adjuvants Market Overview

25.2. Canada Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Vaccine Adjuvants Market

26.1. South America Vaccine Adjuvants Market Overview

26.2. South America Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Vaccine Adjuvants Market

27.1. Brazil Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Vaccine Adjuvants Market

28.1. Middle East Vaccine Adjuvants Market Overview

28.2. Middle East Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Vaccine Adjuvants Market

29.1. Africa Vaccine Adjuvants Market Overview

29.2. Africa Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Vaccine Adjuvants Market Competitive Landscape And Company Profiles

30.1. Vaccine Adjuvants Market Competitive Landscape

30.2. Vaccine Adjuvants Market Company Profiles

30.2.1. GlaxoSmithKline Plc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Novavax Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. SPI Pharma Inc.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Agenus Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. CSL Limited

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Global Vaccine Adjuvants Market Competitive Benchmarking

32. Global Vaccine Adjuvants Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Vaccine Adjuvants Market

34. Vaccine Adjuvants Market Future Outlook and Potential Analysis

34.1 Vaccine Adjuvants Market In 2028 - Countries Offering Most New Opportunities

34.2 Vaccine Adjuvants Market In 2028 - Segments Offering Most New Opportunities

34.3 Vaccine Adjuvants Market In 2028 - Growth Strategies

34.3.1 Market Trend Based Strategies

34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations

35.2. Currencies

35.3. Historic And Forecast Inflation Rates

35.4. Research Inquiries

35.5. The Business Research Company

35.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: GlaxoSmithKline Plc. Financial Performance

Table 76: Novavax Inc. Financial Performance

Table 77: SPI Pharma Inc. Financial Performance

Table 78: Agenus Inc. Financial Performance

Table 79: CSL Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: GlaxoSmithKline Plc. Financial Performance

Figure 76: Novavax Inc. Financial Performance

Figure 77: SPI Pharma Inc. Financial Performance

Figure 78: Agenus Inc. Financial Performance

Figure 79: CSL Limited Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the biosimilars market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the high potency apis market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the covid-19 current therapy market research report 2022 with industry size, share, segments and market growth

Chemicals Global Market Report 2024 – By Type (General Chemical Product, Printing Inks, Toiletries, Soap and Cleaning Compounds, Adhesives, Paints and Coatings, Pesticide and Other Agricultural Chemicals, Chemical Fertilizers, Synthetic Rubber and Fibers, Plastic Material and Resins, Ethyl Alcohol and Other Basic Organic Chemical, Other Basic Inorganic Chemical, Synthetic Dye and Pigment, Industrial Gas, Petrochemicals), By Type of Intermediate Chemicals (Methanol, Ethylene Oxide, Propylene Oxide), By End User (Pharmaceuticals, Agrochemicals, Water Treatment, Construction, Paints and Dyes, Oil & Gas, Rubber Chemicals, Surfactants, Personal Care, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Agricultural Implement Global Market Report 2024 – By Type (Farm Machinery And Equipment, Lawn And Garden Tractor And Home Lawn And Garden Equipment), By Operation (Autonomous, Semi-autonomous, Manual), By Capacity (Small, Medium, Large), By Application (Land Development and Seed Bed Preparation, Sowing and Planting, Weed Management, Plant Protection, Harvesting and Threshing, Post-Harvest and Agro Processing) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Ethylene-Petrochemicals Global Market Report 2024 – By Feedstock (Naphtha, Ethane, Propane, Butane, Other Feedstocks), By Application (Polyethylene, Ethylene oxide, Ethylene benzene, Ethylene dichloride, Vinyl Acetate, Alpha Olefins), By End User Industry (Packaging, Automotive, Construction, Agrochemical, Textile) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Emulsifiers Global Market Report 2024 – By Product (Lecithin, Mono And Di-Glycerides, Stearyl Lactylates, Sorbitan Esters, Polyglycerol Esters, Other Products), By Chemical Structure (Natural, Synthetics, Semi-Synthetics), By Application (Food Emulsifiers, Cosmetics And Personal Care, Oilfield Chemicals, Pharmaceutical, Agrochemicals, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Ethylene Global Market Report 2023 – By Feedstock (Naphtha, Ethane, Propane, Butane, Other Feedstocks), By Application (Polyethylene, Ethylene oxide, Ethylene benzene, Ethylene dichloride, Vinyl Acetate, Alpha Olefins), By End User Industry (Packaging, Automotive, Construction, Agrochemical, Textile) – Market Size, Trends, And Global Forecast 2023-2032

View Report

Genetically Modified Crops Global Market Report 2024 – By Trait (Herbicide Tolerance (HT), Insect Resistance (IR), Stacked Traits (ST), Other Traits), By Crop (Soybean, Cotton, Maize, Oilseed Rape, Other Crops), By Technique (Gene Guns, Electroporation, Microinjection, Agrobacterium, Other Techniques), By Type of Modification (Transgenic, Cis-genic, Sub-genic, Multiple Trait Integration, By Application (Scientific Research, Agriculture Crops) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the vaccine adjuvants market?

How will the vaccine adjuvants market drivers and restraints affect the vaccine adjuvants market dynamics? What forces will shape the vaccine adjuvants industry going forward?

The vaccine adjuvants market major growth driver - rising infectious disease prevalence fuels growth in the vaccine adjuvants market. For further insights on the vaccine adjuvants market, request a sample here

What is the forecast market size or the forecast market value of the vaccine adjuvants market ?

The vaccine adjuvants market size has grown strongly in recent years. It will grow from $1.77 billion in 2023 to $1.91 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing vaccine development, prevalence of infectious diseases, government initiatives and immunization programs, research and development investments, globalization of vaccine distribution. The vaccine adjuvants market size is expected to see strong growth in the next few years. It will grow to $2.62 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine portfolio, global immunization goals, collaborations and partnerships, focus on therapeutic vaccines. Major trends in the forecast period include advancements in adjuvant technologies, focus on immunogenicity enhancement, combination adjuvants for enhanced effectiveness, demand for safer and well-tolerated adjuvants, personalized vaccines and adjuvants. For further insights on the vaccine adjuvants market, request a sample here

How is the vaccine adjuvants market segmented?

The vaccine adjuvants market is segmented
1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other DiseasesFor further insights on the vaccine adjuvants market, request a sample here

Which region has the largest share of the vaccine adjuvants market? What are the other regions covered in the report?

North America was the largest region in the vaccine adjuvants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the vaccine adjuvants market, request a sample here.

Who are the major players in the vaccine adjuvants market?

What are the key trends in the vaccine adjuvants market?

Major trend in the vaccine adjuvants market - surge in strategic partnerships shapes the landscape of the vaccine adjuvants market. For further insights on the vaccine adjuvants market, request a sample here.

What are the major opportunities in the vaccine adjuvants market? What are the strategies for the vaccine adjuvants market?

For detailed insights on the major opportunities and strategies in the vaccine adjuvants market, request a sample here.

How does the vaccine adjuvants market relate to the overall economy and other similar markets?

For detailed insights on vaccine adjuvants market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the vaccine adjuvants industry?

For detailed insights on the mergers and acquisitions in the vaccine adjuvants industry, request a sample here.

What are the key dynamics influencing the vaccine adjuvants market growth? SWOT analysis of the vaccine adjuvants market.

For detailed insights on the key dynamics influencing the vaccine adjuvants market growth and SWOT analysis of the vaccine adjuvants industry, request a sample here.